PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 86 filers reported holding PASSAGE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $666,110 | -32.9% | 1,012,324 | -4.1% | 0.00% | – |
| Q2 2023 | $993,280 | -1.6% | 1,055,222 | +0.1% | 0.00% | – |
| Q1 2023 | $1,009,416 | -34.9% | 1,053,999 | -6.2% | 0.00% | – |
| Q4 2022 | $1,550,703 | -7.6% | 1,123,697 | -16.4% | 0.00% | – |
| Q3 2022 | $1,679,000 | -48.0% | 1,343,942 | -1.8% | 0.00% | – |
| Q2 2022 | $3,227,000 | -68.4% | 1,368,347 | -58.4% | 0.00% | – |
| Q1 2022 | $10,208,000 | -54.0% | 3,292,792 | -5.7% | 0.00% | -100.0% |
| Q4 2021 | $22,171,000 | -28.6% | 3,491,555 | +12.0% | 0.00% | 0.0% |
| Q3 2021 | $31,057,000 | -24.4% | 3,118,023 | +0.5% | 0.00% | 0.0% |
| Q2 2021 | $41,062,000 | -21.7% | 3,101,255 | +3.3% | 0.00% | -50.0% |
| Q1 2021 | $52,468,000 | -7.3% | 3,001,646 | +35.6% | 0.00% | 0.0% |
| Q4 2020 | $56,606,000 | +185.3% | 2,213,700 | +46.3% | 0.00% | +100.0% |
| Q3 2020 | $19,839,000 | -48.4% | 1,513,269 | +7.6% | 0.00% | -50.0% |
| Q2 2020 | $38,448,000 | +293.9% | 1,406,814 | +127.0% | 0.00% | – |
| Q1 2020 | $9,762,000 | – | 619,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |